Alio Raises $18M in First Close of Series C Financing
Posted:
Alio announces its latest round of funding. a medical technology company reinventing the management of chronic disease, announced it has raised $18 million in the initial close of a Series C financing, bringing the total amount the company has raised to over $50 million. Read more here.
Researchers at McGill University have developed an AI tool that can identify rare groups of cells responsible for driving aggressive cancer progression. The tool, called SIDISH, offers a new way to distinguish which cells within a tumour are most strongly…
A new platform from Sophia Genetics is helping the health system improve genomic testing workflows and the quality of cancer care, the company says.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us